Measles Vaccine Market Report

Europe Measles Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 11, 2020
  • PAGES：197
  • REPORT CODE：GMM542870
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Measles Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Measles Vaccine Market Segmentations:

    By Player:

    • Johnson & Johnson

    • CSL Limited

    • Merck

    • Emergent Biosolutions

    • Medimmune

    • China National Biotech Group

    • Novartis

    • GSK

    • Serum Institute of India

    • Sanofi-Pasteur

    • Bavarian Nordic

    • Pfizer

    By Type:

    • Mumps Measles Rubella Vaccine, Live (MMR-II)

    • Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

    By End-User:

    • Children

    • Adults

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Measles Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella Vaccine, Live (MMR-II) from 2014 to 2026

    • 1.3.2 Europe Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Measles Vaccine Market Size and Growth Rate of Children from 2014 to 2026

    • 1.4.2 Europe Measles Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Measles Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Measles Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Mumps Measles Rubella Vaccine, Live (MMR-II)

      • 3.4.2 Market Size and Growth Rate of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

    4 Segmentation of Measles Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Measles Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Children for Construction

      • 4.4.2 Market Size and Growth Rate of Adults for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Measles Vaccine Production Analysis by Top Regions

    • 5.2 Europe Measles Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Measles Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Measles Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Measles Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Measles Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Measles Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Measles Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Measles Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Measles Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Measles Vaccine Landscape Analysis

    • 7.1 Germany Measles Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Measles Vaccine Landscape Analysis by Major End-Users

    8. UK Measles Vaccine Landscape Analysis

    • 8.1 UK Measles Vaccine Landscape Analysis by Major Types

    • 8.2 UK Measles Vaccine Landscape Analysis by Major End-Users

    9. France Measles Vaccine Landscape Analysis

    • 9.1 France Measles Vaccine Landscape Analysis by Major Types

    • 9.2 France Measles Vaccine Landscape Analysis by Major End-Users

    10. Italy Measles Vaccine Landscape Analysis

    • 10.1 Italy Measles Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Measles Vaccine Landscape Analysis by Major End-Users

    11. Spain Measles Vaccine Landscape Analysis

    • 11.1 Spain Measles Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Measles Vaccine Landscape Analysis by Major End-Users

    12. Poland Measles Vaccine Landscape Analysis

    • 12.1 Poland Measles Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Measles Vaccine Landscape Analysis by Major End-Users

    13. Russia Measles Vaccine Landscape Analysis

    • 13.1 Russia Measles Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Measles Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Measles Vaccine Landscape Analysis

    • 14.1 Switzerland Measles Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Measles Vaccine Landscape Analysis by Major End-Users

    15. Turkey Measles Vaccine Landscape Analysis

    • 15.1 Turkey Measles Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Measles Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Measles Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Measles Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Measles Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Measles Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Measles Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Measles Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Measles Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Measles Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Measles Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Measles Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Measles Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Johnson & Johnson

      • 19.1.1 Johnson & Johnson Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 CSL Limited

      • 19.2.1 CSL Limited Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Merck

      • 19.3.1 Merck Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Emergent Biosolutions

      • 19.4.1 Emergent Biosolutions Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Medimmune

      • 19.5.1 Medimmune Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 China National Biotech Group

      • 19.6.1 China National Biotech Group Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Novartis

      • 19.7.1 Novartis Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 GSK

      • 19.8.1 GSK Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Serum Institute of India

      • 19.9.1 Serum Institute of India Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Sanofi-Pasteur

      • 19.10.1 Sanofi-Pasteur Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Bavarian Nordic

      • 19.11.1 Bavarian Nordic Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Pfizer

      • 19.12.1 Pfizer Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 98 Figures and 182 Tables)

    • Figure Product Picture

    • Figure Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella Vaccine, Live (MMR-II) Market, 2015 - 2026 (USD Million)

    • Figure Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Market, 2015 - 2026 (USD Million)

    • Figure Measles Vaccine Market Size and Growth Rate of Children from 2014 to 2026

    • Figure Measles Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • Figure Germany Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Measles Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Measles Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Measles Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Measles Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Measles Vaccine by Different Types from 2014 to 2026

    • Figure Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella Vaccine, Live (MMR-II) Market, 2015 - 2026 (USD Million)

    • Figure Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Measles Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Measles Vaccine by Different End-Users from 2014 to 2026

    • Figure Measles Vaccine Market Size and Growth Rate of Children from 2014 to 2026

    • Figure Measles Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • Table Europe Measles Vaccine Production by Major Regions

    • Table Europe Measles Vaccine Production Share by Major Regions

    • Figure Europe Measles Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Measles Vaccine Consumption by Major Regions

    • Table Europe Measles Vaccine Consumption Share by Major Regions

    • Table Germany Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table France Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Measles Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Measles Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Measles Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Measles Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Measles Vaccine Consumption by Types from 2014 to 2026

    • Table UK Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Measles Vaccine Consumption by Types from 2014 to 2026

    • Table France Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Measles Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Measles Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Measles Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Measles Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Johnson & Johnson Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Johnson & Johnson Product benchmarking

    • Table Johnson & Johnson Strategic initiatives

    • Table Johnson & Johnson SWOT analysis

    • Table CSL Limited Profiles

    • Table CSL Limited Production, Value, Price, Gross Margin 2014-2019

    • Table CSL Limited Product benchmarking

    • Table CSL Limited Strategic initiatives

    • Table CSL Limited SWOT analysis

    • Table Merck Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Merck Product benchmarking

    • Table Merck Strategic initiatives

    • Table Merck SWOT analysis

    • Table Emergent Biosolutions Profiles

    • Table Emergent Biosolutions Production, Value, Price, Gross Margin 2014-2019

    • Table Emergent Biosolutions Product benchmarking

    • Table Emergent Biosolutions Strategic initiatives

    • Table Emergent Biosolutions SWOT analysis

    • Table Medimmune Profiles

    • Table Medimmune Production, Value, Price, Gross Margin 2014-2019

    • Table Medimmune Product benchmarking

    • Table Medimmune Strategic initiatives

    • Table Medimmune SWOT analysis

    • Table China National Biotech Group Profiles

    • Table China National Biotech Group Production, Value, Price, Gross Margin 2014-2019

    • Table China National Biotech Group Product benchmarking

    • Table China National Biotech Group Strategic initiatives

    • Table China National Biotech Group SWOT analysis

    • Table Novartis Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis Product benchmarking

    • Table Novartis Strategic initiatives

    • Table Novartis SWOT analysis

    • Table GSK Profiles

    • Table GSK Production, Value, Price, Gross Margin 2014-2019

    • Table GSK Product benchmarking

    • Table GSK Strategic initiatives

    • Table GSK SWOT analysis

    • Table Serum Institute of India Profiles

    • Table Serum Institute of India Production, Value, Price, Gross Margin 2014-2019

    • Table Serum Institute of India Product benchmarking

    • Table Serum Institute of India Strategic initiatives

    • Table Serum Institute of India SWOT analysis

    • Table Sanofi-Pasteur Profiles

    • Table Sanofi-Pasteur Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi-Pasteur Product benchmarking

    • Table Sanofi-Pasteur Strategic initiatives

    • Table Sanofi-Pasteur SWOT analysis

    • Table Bavarian Nordic Profiles

    • Table Bavarian Nordic Production, Value, Price, Gross Margin 2014-2019

    • Table Bavarian Nordic Product benchmarking

    • Table Bavarian Nordic Strategic initiatives

    • Table Bavarian Nordic SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US